MedPath

Effect of ARB on Blood Pressure and Quality of Life

Not Applicable
Completed
Conditions
Hypertension
Registration Number
JPRN-UMIN000009469
Lead Sponsor
Study group for Hypertension medical treatment in Saga
Brief Summary

azilsultan medical treatment group, the blood pressure tends to fall.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

1) Secondary hypertensive patient 2) Patients with moderate or severe cardiac dysfunction (NYHA class 3 or 4) 3) Pregnant and/or expecting women 4) Patients with severe impaired liver function 5)Patients with kidney dysfunction(sCr>=2.0mg/dl) 6) Patients with a history of hypersensitivity to the azilsultan 7)Patients who are considered not eligible for the study by the attending doctor due to other reasons

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
he amount of change of the ambulatory blood pressure at baseline and after 3 months of use
Secondary Outcome Measures
NameTimeMethod
1) The Quantity of change of the QOL score at baseline and after 3 months of use. 2) The amount of change of a blood test value at baseline and after 3 months of use. 3) The amount of change of home blood pressure at baseline and after 3 months of use. 4) Safety which led overall treatment term/time.
© Copyright 2025. All Rights Reserved by MedPath